Relay Therapeutics, Inc.

RLAY stock score: 50/100

$18.41 · -0.22% · Scored Oct 21, 2026

Technical
67
Fundamental
33
News
51

The reading

Relay Therapeutics (RLAY) scores 50 out of 100, which reads neutral, higher than 61% of Healthcare stocks and 41% of the 4,166 US stocks we score.

The composite is technicals and fundamentals weighted equally: technicals read 67, fundamentals 33.

Among the fundamentals, Quick Ratio at 100 and Price Target at 100 score highest, while Earnings Profitability (Quarterly) at 0 weighs the most against it.

On the daily chart, trend-following indicators average 64 and contrarian oscillators 49.

News sentiment is neutral at 51; it is shown, not counted in the composite.

Since Jul 25, 2026 the composite has ranged from 44 to 70, and it is down 19 points over the period.

What’s driving the score

The strongest and weakest of the scorers that count toward RLAY’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.

Fundamental

33

Pulling it up

  • Quick Ratio100

    Quick ratio measures a company's ability to meet short-term obligations with liquid assets.

  • Price Target100

    Price target score compares the current stock price to analyst consensus targets.

  • Current Ratio100

    Current ratio measures ability to pay short-term liabilities with current assets.

Holding it back

  • Earnings Profitability (Quarterly)0

    Earnings Profitability (Quarterly) measures recent profitability using trailing 12-month quarterly data.

  • Earnings Quality (Annual)0

    Earnings Quality (Annual) assesses absolute profitability independent of growth, measuring whether the company is profitable, its earnings yield (earnings/market cap), profit margins, and consistency.

  • EV/Revenue0

    EV/Revenue compares the whole company's value, debt included, with its sales.

38 weighted scorers; 3 had no data today and are left out rather than counted as zero.

Technical · daily

61

Pulling it up

  • 52-Week Change100

    The price change over the last 52 weeks.

  • S&P 500 52W Comparison100

    S&P 500 52-week comparison evaluates the stock's annual performance relative to the broader market.

  • EMA 20095

    Exponential Moving Average (200-period) is a crucial long-term trend indicator that reacts faster than SMA-200.

Holding it back

  • Candlestick Patterns0

    Candlestick patterns recognize specific price formations that historically suggest continuation or reversal.

  • Ichimoku Cloud0

    Ichimoku Cloud is a comprehensive indicator showing support/resistance, trend direction, and momentum.

  • TRIX12

    TRIX is a momentum oscillator that filters out short-term noise by triple-smoothing price data.

62 weighted scorers; 3 had no data today and are left out rather than counted as zero.

News · shown, not counted

Global News
51

Technical score by timeframe

ChartScoreWeight
Hourly551
Daily613
Weekly672
Monthly732
Quarterly732

Composite score, last 90 days

05010050Jul 25, 2026Oct 21, 2026Jul 25, 2026: 69Jul 26, 2026: 69Jul 27, 2026: 70Jul 28, 2026: 70Jul 29, 2026: 55Jul 30, 2026: 58Jul 31, 2026: 56Aug 2, 2026: 52Aug 3, 2026: 53Aug 5, 2026: 54Aug 6, 2026: 53Aug 7, 2026: 53Aug 8, 2026: 54Aug 9, 2026: 54Aug 10, 2026: 54Aug 11, 2026: 53Aug 12, 2026: 53Aug 13, 2026: 53Aug 14, 2026: 53Aug 15, 2026: 52Aug 16, 2026: 53Aug 17, 2026: 53Aug 18, 2026: 53Aug 19, 2026: 54Aug 20, 2026: 52Aug 22, 2026: 50Aug 23, 2026: 50Aug 24, 2026: 50Aug 25, 2026: 51Aug 26, 2026: 49Aug 27, 2026: 49Aug 28, 2026: 48Aug 29, 2026: 48Aug 30, 2026: 48Aug 31, 2026: 47Sep 1, 2026: 49Sep 2, 2026: 50Sep 3, 2026: 53Sep 4, 2026: 49Sep 5, 2026: 49Sep 6, 2026: 49Sep 7, 2026: 49Sep 8, 2026: 51Sep 9, 2026: 48Sep 10, 2026: 49Sep 11, 2026: 48Sep 12, 2026: 49Sep 13, 2026: 49Sep 14, 2026: 49Sep 15, 2026: 48Sep 16, 2026: 48Sep 17, 2026: 50Sep 18, 2026: 48Sep 19, 2026: 48Sep 20, 2026: 48Sep 21, 2026: 47Sep 22, 2026: 50Sep 23, 2026: 49Sep 24, 2026: 48Sep 25, 2026: 46Sep 26, 2026: 46Sep 27, 2026: 46Sep 28, 2026: 46Sep 29, 2026: 48Sep 30, 2026: 48Oct 1, 2026: 48Oct 2, 2026: 51Oct 3, 2026: 50Oct 4, 2026: 51Oct 5, 2026: 51Oct 6, 2026: 50Oct 7, 2026: 46Oct 8, 2026: 45Oct 9, 2026: 46Oct 10, 2026: 46Oct 11, 2026: 46Oct 12, 2026: 47Oct 13, 2026: 45Oct 14, 2026: 45Oct 15, 2026: 46Oct 16, 2026: 44Oct 17, 2026: 44Oct 18, 2026: 44Oct 19, 2026: 46Oct 20, 2026: 49Oct 21, 2026: 50
Show the daily numbers
DateComposite
Oct 21, 202650
Oct 20, 202649
Oct 19, 202646
Oct 18, 202644
Oct 17, 202644
Oct 16, 202644
Oct 15, 202646
Oct 14, 202645
Oct 13, 202645
Oct 12, 202647
Oct 11, 202646
Oct 10, 202646
Oct 9, 202646
Oct 8, 202645
Oct 7, 202646
Oct 6, 202650
Oct 5, 202651
Oct 4, 202651
Oct 3, 202650
Oct 2, 202651
Oct 1, 202648
Sep 30, 202648
Sep 29, 202648
Sep 28, 202646
Sep 27, 202646
Sep 26, 202646
Sep 25, 202646
Sep 24, 202648
Sep 23, 202649
Sep 22, 202650
Sep 21, 202647
Sep 20, 202648
Sep 19, 202648
Sep 18, 202648
Sep 17, 202650
Sep 16, 202648
Sep 15, 202648
Sep 14, 202649
Sep 13, 202649
Sep 12, 202649
Sep 11, 202648
Sep 10, 202649
Sep 9, 202648
Sep 8, 202651
Sep 7, 202649
Sep 6, 202649
Sep 5, 202649
Sep 4, 202649
Sep 3, 202653
Sep 2, 202650
Sep 1, 202649
Aug 31, 202647
Aug 30, 202648
Aug 29, 202648
Aug 28, 202648
Aug 27, 202649
Aug 26, 202649
Aug 25, 202651
Aug 24, 202650
Aug 23, 202650
Aug 22, 202650
Aug 20, 202652
Aug 19, 202654
Aug 18, 202653
Aug 17, 202653
Aug 16, 202653
Aug 15, 202652
Aug 14, 202653
Aug 13, 202653
Aug 12, 202653
Aug 11, 202653
Aug 10, 202654
Aug 9, 202654
Aug 8, 202654
Aug 7, 202653
Aug 6, 202653
Aug 5, 202654
Aug 3, 202653
Aug 2, 202652
Jul 31, 202656
Jul 30, 202658
Jul 29, 202655
Jul 28, 202670
Jul 27, 202670
Jul 26, 202669
Jul 25, 202669

Key facts

Market cap
$4.0B
Sector
Healthcare
Industry
Biotechnology
Beta
1.73
Risk grade (1–10)
8
Next earnings
Nov 5, 2026

Biotechnology peers

CompanyMarket capScore
TNGX Tango Therapeutics$4.5B55
DNTH Dianthus Therapeutics$4.4B45
EWTX Edgewise Therapeutics$4.3B46
ARQT Arcutis Biotherapeutics$4.0B61
ABCL AbCellera Biologics$4.0B52
LEGN Legend Biotech$3.6B41

Questions

What is RLAY's stock score today?

RLAY scores 50/100 (Neutral) as of Oct 21, 2026: technical 67, fundamental 33, and news sentiment 51, which is shown but not counted. Scores are recomputed every night.

Is RLAY a buy?

The score is not a buy or sell recommendation. A 50 says the technical and fundamental signals we measure lean neutral today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.

How is the RLAY score calculated?

100 weighted scorers feed it today: 38 fundamental, scored against Healthcare ranges, and 62 technical on the daily chart, with 5 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.

Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.